capecitabine - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
Capecitabine Sandoz capecitabine 500mg film coated tablet blister pack AUST R: 201800Active ingredients:
capecitabine
Dosage form:
Tablet, film coated
Sponsor:
Sandoz Pty Ltd
Phone:
1800 726 369
|
From
29 Aug 2024
to
12 Sep 2025
|
Shortage status:
Current
Availability:
Unavailable
Reason:
Manufacturing
Management action:
The sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. Please contact the approval holder Pro Pharmaceuticals Group on 1300 077 674.
|
XELABINE capecitabine 500 mg film-coated tablet blister pack AUST R: 213045Active ingredients:
capecitabine
Dosage form:
Tablet, film coated
Sponsor:
Viatris Pty Ltd
Phone:
1800 314 527
|
From
05 Feb 2025
to
22 Jul 2025
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Unexpected increase in consumer demand
Management action:
The sponsor is working to expedite the next shipment. An unregistered product has been approved for supply under Section 19A. Please contact the approval holder Pro Pharmaceuticals Group on 1300 077 674.
|
CAPECITABINE-DRLA capecitabine 500 mg tablet blister pack AUST R: 200933Active ingredients:
capecitabine
Dosage form:
Tablet, film coated
Sponsor:
Dr Reddys Laboratories Australia Pty Ltd
Phone:
0427 306 107
|
Deletion from market:
31 Jan 2024
|
Shortage status:
Discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
Other brands are available
|